Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA Shuts The Door On Celgene’s Abraxane Petition
Petition Filed In 2015 Could Have Delayed Competition
Jul 09 2021
•
By
Dean Rudge
The FDA mostly denied the 2015 petition • Source: Shutterstock
More from Regulation
More from Policy & Regulation